MX2015005498A - Nuevos compuestos antibacterianos y aplicaciones biologicas de los mismos. - Google Patents

Nuevos compuestos antibacterianos y aplicaciones biologicas de los mismos.

Info

Publication number
MX2015005498A
MX2015005498A MX2015005498A MX2015005498A MX2015005498A MX 2015005498 A MX2015005498 A MX 2015005498A MX 2015005498 A MX2015005498 A MX 2015005498A MX 2015005498 A MX2015005498 A MX 2015005498A MX 2015005498 A MX2015005498 A MX 2015005498A
Authority
MX
Mexico
Prior art keywords
alkyl
ora
nrarb
fluoroalkyl
biological applications
Prior art date
Application number
MX2015005498A
Other languages
English (en)
Spanish (es)
Inventor
Dmytro Atamanyuk
Vincent Gerusz
Francois Moreau
Vivien Henryon
Jérome Monbrun
Etienne Airiau
Original Assignee
Biodim Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodim Lab filed Critical Biodim Lab
Publication of MX2015005498A publication Critical patent/MX2015005498A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emergency Medicine (AREA)
MX2015005498A 2012-10-29 2013-10-28 Nuevos compuestos antibacterianos y aplicaciones biologicas de los mismos. MX2015005498A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306350.5A EP2725029A1 (en) 2012-10-29 2012-10-29 New antibacterial compounds and biological applications thereof
PCT/EP2013/072526 WO2014067904A1 (en) 2012-10-29 2013-10-28 New antibacterial compounds and biological applications thereof

Publications (1)

Publication Number Publication Date
MX2015005498A true MX2015005498A (es) 2016-01-08

Family

ID=47278726

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005498A MX2015005498A (es) 2012-10-29 2013-10-28 Nuevos compuestos antibacterianos y aplicaciones biologicas de los mismos.

Country Status (13)

Country Link
US (1) US9975911B2 (https=)
EP (2) EP2725029A1 (https=)
JP (1) JP6389463B2 (https=)
KR (1) KR20150105300A (https=)
CN (1) CN104936966A (https=)
AU (1) AU2013339557A1 (https=)
BR (1) BR112015009546A2 (https=)
CA (1) CA2889503A1 (https=)
CL (1) CL2015000985A1 (https=)
HK (1) HK1211034A1 (https=)
MX (1) MX2015005498A (https=)
RU (1) RU2015120376A (https=)
WO (1) WO2014067904A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102282155B (zh) 2008-12-02 2017-06-09 日本波涛生命科学公司 磷原子修饰的核酸的合成方法
RU2612521C2 (ru) 2009-07-06 2017-03-09 Онтории, Инк. Новые пролекарства нуклеиновых кислот и способы их применения
JP5868324B2 (ja) 2010-09-24 2016-02-24 株式会社Wave Life Sciences Japan 不斉補助基
CN103796657B (zh) 2011-07-19 2017-07-11 波涛生命科学有限公司 合成官能化核酸的方法
PL2872485T3 (pl) 2012-07-13 2021-05-31 Wave Life Sciences Ltd. Asymetryczna grupa pomocnicza
BR112016016400A2 (pt) 2014-01-16 2017-10-03 Wave Life Sciences Ltd Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
CN108484619A (zh) * 2018-04-26 2018-09-04 福建师范大学泉港石化研究院 一种罗丹明基Fe3+荧光探针及其制备方法
CN108484620A (zh) * 2018-04-26 2018-09-04 福建师范大学泉港石化研究院 一种水溶性罗丹明基Cu2+荧光探针及其合成方法
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
SG11202101255UA (en) 2018-08-09 2021-03-30 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
RU2770537C1 (ru) * 2021-09-15 2022-04-18 федеральное государственное автономное образовательное учреждение высшего образования «Казанский (Приволжский) федеральный университет» (ФГАОУ ВО КФУ) Фосфорилсодержащие четвертичные соли аммония с высшими алкильными заместителями, обладающие бактерицидной и фунгицидной активностью
CN116905145B (zh) * 2023-08-07 2026-03-06 安徽恒益智能科技股份有限公司 一种抗菌包芯纱线及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206156A (en) * 1976-07-27 1980-06-03 Fujisawa Pharmaceutical Company, Limited Hydroxyaminohydrocarbonphosphonic acids
GB1580899A (en) 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
JPS5463024A (en) * 1977-10-27 1979-05-21 Fujisawa Pharmaceut Co Ltd 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use
JPS5562019A (en) * 1978-09-14 1980-05-10 Fujisawa Pharmaceut Co Ltd Antibacterial
US4693742A (en) 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
CA1340588C (en) 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
BR9912062A (pt) * 1998-07-15 2001-04-03 Hassan Jomaa Compostos orgânicos fosforosos e seu uso
US6911450B1 (en) 2001-01-29 2005-06-28 Universite De Geneve Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
FR2872158B1 (fr) 2004-06-28 2006-11-03 Merck Sante Soc Par Actions Si Nouveaux composes diazeniumdiolates, leur procede de preparation et leur utilisation therapeutique
EP1669365A1 (en) 2004-12-03 2006-06-14 Mutabilis SA Method for preparing enzymatic substrate analogs as inhibitors of bacterial heptosyl-transferases
WO2008033747A2 (en) 2006-09-11 2008-03-20 Curis, Inc. Multi-functional small molecules as anti-proliferative agents
AU2007301607A1 (en) 2006-09-25 2008-04-03 Mutabilis Sa Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
EP2141164A1 (en) 2008-07-01 2010-01-06 Mutabilis New 1,2,4-triazine derivatives and biological applications thereof
HRP20150778T1 (hr) * 2009-01-23 2015-08-28 Euro-Celtique S.A. Derivati hidroksamske kiseline
WO2011045703A2 (en) 2009-10-13 2011-04-21 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
EP2377853A1 (en) 2010-04-09 2011-10-19 Universite de Rouen 7,11-Methanocycloocta[b]quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
EP2646451A2 (en) 2010-12-01 2013-10-09 Laboratoire Biodim Heptose derivatives for use in the treatment of bacterial infections
US9593136B2 (en) * 2011-07-01 2017-03-14 The George Washington University Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

Also Published As

Publication number Publication date
WO2014067904A1 (en) 2014-05-08
EP2912043B1 (en) 2016-11-30
KR20150105300A (ko) 2015-09-16
AU2013339557A1 (en) 2015-04-30
EP2912043A1 (en) 2015-09-02
US20150291636A1 (en) 2015-10-15
HK1211034A1 (en) 2016-05-13
US9975911B2 (en) 2018-05-22
JP2015536928A (ja) 2015-12-24
BR112015009546A2 (pt) 2017-07-04
RU2015120376A (ru) 2016-12-20
JP6389463B2 (ja) 2018-09-12
EP2725029A1 (en) 2014-04-30
CA2889503A1 (en) 2014-05-08
CN104936966A (zh) 2015-09-23
CL2015000985A1 (es) 2016-05-13

Similar Documents

Publication Publication Date Title
MX2015005498A (es) Nuevos compuestos antibacterianos y aplicaciones biologicas de los mismos.
DOP2022000038A (es) Nanopartícula lipídicas mejoradas para el suministro de ácidos nucleicos
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
NZ628328A (en) Rna formulation for immunotherapy
ME02910B (me) Spojevi tetrahidropirolotiazina
EP2702994A3 (en) Methods of administering pirfenidone therapy
IL244527B (en) An isolated strain of Clonostachis rosea for use as a biological control agent
NZ734035A (en) Nasal powder formulation for treatment of hypoglycemia
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
EP2604629A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF NUTRIDARY CANCER WITH HPV PLASMODIUM AND IMMUNITY AMPLIFIER
EP2868324A4 (en) HYALURONIC ACID SHORTS WITH A ROSEMARY EXTRACT AND RETINOL ACETATE
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
WO2014116144A3 (ru) Циклический октапептид и применение его комплексов с адионуклидами для получения лекарственных средств
CN202409531U (zh) 取药勺
AU365639S (en) 16mm scale model of victorian railways nb car
CN302043288S (zh) 鼠标
CN302008336S (zh) 吸入器
CN302577479S (zh) 剂量容器
CN302234852S (zh) 按摩器
CN302112133S (zh) 哑铃
CN302215050S (zh) 锁(三)
CN302568384S (zh) 中药包
CN302165566S (zh) 削笔器
UA27065S (uk) Набір графічних користувацьких інтерфейсів сайту «7 работ»
CN302340235S (zh) 戒指(触电)